Skip to main content
. Author manuscript; available in PMC: 2015 Nov 13.
Published in final edited form as: Mol Diagn Ther. 2014 Aug;18(4):409–418. doi: 10.1007/s40291-014-0091-6

Fig. 4.

Fig. 4

Caveats of tumor cellularity estimation. Number of nuclei rather than surface area of nuclei or entire cells should dictate % tumor cellularity estimates (a). This may be difficult for human “eyeball” estimates—here, tumor cellularity is estimated at 50 % according to surface area, but the mutant allele (assuming heterozygosity) is 20 %. Nuclear truncation in tissue section also leads to overestimated tumor contents (b)